<DOC>
	<DOCNO>NCT00830128</DOCNO>
	<brief_summary>This study ass safety efficacy long-term use pregabalin dose 450 mg/day patient fibromyalgia complete 16 week dose Study A0081208 ( NCT00830167 ) .</brief_summary>
	<brief_title>A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin In Patients With Fibromyalgia</brief_title>
	<detailed_description />
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Patients must meet inclusion criterion precede fibromyalgia Protocol A0081208 , must receive pregabalin/placebo doubleblind condition . Patients may participate study experience serious adverse event previous fibromyalgia Study A0081208 ; determine related study medication investigator sponsor .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>